{"id":"NCT00449033","sponsor":"Bayer","briefTitle":"A Phase III Randomized, Double-blind, Placebo Controlled Trial Comparing the Efficacy of Gemcitabine, Cisplatin and Sorafenib to Gemcitabine, Cisplatin and Placebo in First-Line Treatment of Patients With Stage IIIb With Effusion and Stage IV Non-Small Cell Lung Cancer (NSCLC)","officialTitle":"A Phase III Randomized, Double-blind, Placebo Controlled Trial Comparing the Efficacy of Gemcitabine, Cisplatin and Sorafenib to Gemcitabine, Cisplatin and Placebo in First-Line Treatment of Patients With Stage IIIb With Effusion and Stage IV Non-Small Cell Lung Cancer (NSCLC)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-02","primaryCompletion":"2010-04","completion":"2011-06","firstPosted":"2007-03-19","resultsPosted":"2011-09-09","lastUpdate":"2015-04-23"},"enrollment":904,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Carcinoma, Non-Small-Cell Lung"],"interventions":[{"type":"DRUG","name":"Sorafenib (Nexavar, BAY43-9006)","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Gemcitabine","otherNames":[]},{"type":"DRUG","name":"Cisplatin","otherNames":[]}],"arms":[{"label":"Sorafenib (Nexavar, BAY43-9006) + GC","type":"EXPERIMENTAL"},{"label":"Placebo + GC","type":"PLACEBO_COMPARATOR"}],"summary":"Evaluation of gemcitabine and cisplatin in combination with either sorafenib or placebo for the treatment of patients with advanced Non-Small Cell Lung Cancer (NSCLC)","primaryOutcome":{"measure":"Overall Survival (OS) in the ITT (Non-squamous) Population","timeFrame":"from randomization of the first patient until 38 months or date of death of any cause whichever came first","effectByArm":[{"arm":"Sorafenib (Nexavar, BAY43-9006) + GC","deltaMin":376,"sd":null},{"arm":"Placebo + GC","deltaMin":379,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.401"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":15,"exclusionCount":2},"locations":{"siteCount":122,"countries":["Austria","Belgium","Brazil","Canada","China","Cyprus","Finland","France","Germany","Greece","Hungary","Israel","Italy","Mexico","Netherlands","Spain","Switzerland","United Kingdom"]},"refs":{"pmids":["22851564"],"seeAlso":["http://www.clinicaltrialsregister.eu"]},"adverseEventsSummary":{"seriousAny":{"events":270,"n":452},"commonTop":["Nausea","Fatigue","Platelets","Hemoglobin","Neutrophils"]}}